PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.63%
Negative revenue growth while ON stands at 3.68%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-7.29%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-5.86%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.38%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-0.12%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.26%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
13.02%
Dividend growth of 13.02% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-8.03%
Negative OCF growth while ON is at 76.06%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-10.39%
Negative FCF growth while ON is at 369.77%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
70.78%
Similar 10Y revenue/share CAGR to ON's 64.40%. Walter Schloss might see both firms benefiting from the same long-term demand.
29.09%
5Y revenue/share CAGR under 50% of ON's 69.74%. Michael Burry would suspect a significant competitive gap or product weakness.
3.75%
3Y revenue/share CAGR under 50% of ON's 16.26%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
60.55%
10Y OCF/share CAGR under 50% of ON's 221.90%. Michael Burry would worry about a persistent underperformance in cash creation.
50.79%
5Y OCF/share CAGR is similar to ON's 55.09%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
42.19%
3Y OCF/share CAGR above 1.5x ON's 1.92%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
177.33%
Net income/share CAGR above 1.5x ON's 103.30% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
49.47%
Positive 5Y CAGR while ON is negative. John Neff might view this as a strong mid-term relative advantage.
200.49%
3Y net income/share CAGR above 1.5x ON's 111.91%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
31.01%
Below 50% of ON's 277.10%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
26.82%
Below 50% of ON's 61.77%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
2.97%
Below 50% of ON's 14.83%. Michael Burry suspects a serious short-term disadvantage in building book value.
1232.73%
Stable or rising dividend while ON is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
183.53%
Dividend/share CAGR of 183.53% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
100.21%
3Y dividend/share CAGR of 100.21% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-15.64%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
1.88%
Inventory growth well above ON's 0.77%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.99%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
0.49%
Positive BV/share change while ON is negative. John Neff sees a clear edge over a competitor losing equity.
-0.06%
We’re deleveraging while ON stands at 0.76%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.33%
Our R&D shrinks while ON invests at 18.74%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-7.34%
We cut SG&A while ON invests at 3.71%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.